Testing a new ultrasound imaging technique for breast, kidney, and liver lesions

This trial is testing a new ultrasound imaging technique called Contrast Enhanced Super-Resolution (CESR) imaging that uses an ultrasound contrast agent (Definity®) to get clearer pictures of suspicious areas in the breast, kidney, or liver. Researchers want to see if this new imaging method can better tell the difference between cancer and benign (non-cancerous) lesions compared to standard ultrasound imaging. If successful, this could help doctors make more confident diagnoses before patients undergo biopsy.

Standard ultrasound imaging sometimes cannot clearly distinguish between cancerous and benign lesions, which can lead to unnecessary biopsies or missed diagnoses. This trial aims to see if the new imaging technique provides better clarity and accuracy, potentially improving how doctors evaluate suspicious areas in these organs.